Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21732 | 25083925 | Prog Lipid Res | Recent advances in pharmacotherapy for hypertriglyceridemia. | 2014 | Details |
| A21733 | 25083607 | Gastroenterology | Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. | 2014 | Details |
| A21734 | 25083081 | World J Gastroenterol | Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease. | 2014 | Details |
| A21735 | 25083080 | World J Gastroenterol | Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? | 2014 | Details |
| A21736 | 25083079 | World J Gastroenterol | Nonalcoholic fatty liver disease and the heart in children and adolescents. | 2014 | Details |
| A21737 | 25083078 | World J Gastroenterol | Epidemiology of fatty liver: an update. | 2014 | Details |
| A21738 | 25083077 | World J Gastroenterol | Translational approaches: from fatty liver to non-alcoholic steatohepatitis. | 2014 | Details |
| A21739 | 25083076 | World J Gastroenterol | Role of liver biopsy in nonalcoholic fatty liver disease. | 2014 | Details |
| A21740 | 25080922 | Am J Physiol Gastrointest Liver Physiol | Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease. | 2014 | Details |
| A21741 | 25080921 | Toxicol Sci | Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis. | 2014 | Details |
| A21743 | 25075578 | Braz J Med Biol Res | Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats. | 2014 | Details |
| A21744 | 25074471 | Clin Sci (Lond) | CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients. | 2015 | Details |
| A21746 | 25073966 | Pediatr Obes | The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children. | 2014 | Details |
| A21747 | 25073669 | Korean J Gastroenterol | [Comparison on the efficacy and safety of biphenyl dimethyl dicarboxylate and ursodeoxycholic acid in patients with abnormal alanine aminotransferase: multicenter, double-blinded, randomized, active-controlled clinical trial]. | 2014 | Details |
| A21749 | 25072958 | Biochim Biophys Acta | A cell-type-specific role for murine Commd1 in liver inflammation. | 2014 | Details |
| A21750 | 25072743 | J Med Food | Functional and metabolic disorders in celiac disease: new implications for nutritional treatment. | 2014 | Details |
| A21751 | 25072708 | PLoS One | Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3β,25-diol, disulfate. | 2014 | Details |
| A21752 | 25071328 | World J Gastroenterol | Role of diet and lifestyle changes in nonalcoholic fatty liver disease. | 2014 | Details |
| A21753 | 25071327 | World J Gastroenterol | Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. | 2014 | Details |
| A21754 | 25071314 | World J Gastroenterol | Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? | 2014 | Details |
| A21755 | 25069836 | Eat Weight Disord | The therapy of insulin resistance in other diseases besides type 2 diabetes. | 2014 | Details |
| A21756 | 25069572 | Dig Dis Sci | Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea. | 2014 | Details |
| A21757 | 25068001 | World J Hepatol | CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2014 | Details |
| A21758 | 25066281 | Liver Int | Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice. | 2014 | Details |
| A21759 | 25066109 | Diabetes Metab Res Rev | GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease. | 2014 | Details |
| A21760 | 25065280 | Arch Iran Med | Regulation of adipokines by polyunsaturated fatty acids in a rat model of non-alcoholic steatohepatitis. | 2014 | Details |
| A21761 | 25064435 | J Hepatol | Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent. | 2014 | Details |
| A21762 | 25063410 | J Ultrasound Med | Focal fatty sparing usually does not arise in preexisting nonalcoholic diffuse homogeneous fatty liver. | 2014 | Details |
| A21763 | 25063232 | Int J Biochem Cell Biol | Exercise alters liver mitochondria phospholipidomic profile and mitochondrial activity in non-alcoholic steatohepatitis. | 2014 | Details |
| A21764 | 30258859 | Genes Dis | The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis. | 2014 | Details |
| A21765 | 25061561 | Mol Metab | Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels. | 2014 | Details |
| A21766 | 25061559 | Mol Metab | ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload. | 2014 | Details |
| A21767 | 25060692 | Metabolism | Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells. | 2014 | Details |
| A21768 | 25060399 | J Dig Dis | Progression of liver disease in non-alcoholic fatty liver disease: a prospective clinicopathological follow-up study. | 2014 | Details |
| A21769 | 25060337 | Sci Rep | Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. | 2014 | Details |
| A21770 | 25059108 | Obes Rev | Metabolically healthy and unhealthy obese--the 2013 Stock Conference report. | 2014 | Details |
| A21771 | 25057109 | J Mol Endocrinol | oxLDL induces injury and defenestration of human liver sinusoidal endothelial cells via LOX1. | 2014 | Details |
| A21772 | 25057104 | Nutrients | Pinus densiflora Sieb. et Zucc. alleviates lipogenesis and oxidative stress during oleic acid-induced steatosis in HepG2 cells. | 2014 | Details |
| A21773 | 25054002 | Biomed Rep | Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes. | 2014 | Details |
| A21774 | 25053716 | Gut | Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. | 2014 | Details |
| A21775 | 25052889 | World J Surg Oncol | Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study. | 2014 | Details |
| A21776 | 25051256 | Mol Med Rep | Protective effects and mechanisms of total alkaloids of Rubus alceaefolius Poir on non‑alcoholic fatty liver disease in rats. | 2014 | Details |
| A21777 | 25051240 | Metab Syndr Relat Disord | Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome. | 2014 | Details |
| A21779 | 25050550 | PLoS Med | Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. | 2014 | Details |
| A21780 | 25048953 | J Hepatol | Cyclophilin inhibition as potential therapy for liver diseases. | 2014 | Details |
| A21781 | 25048951 | J Hepatol | CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis. | 2014 | Details |
| A21782 | 25048611 | PLoS One | Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR signalling pathway. | 2014 | Details |
| A21783 | 25047370 | Wien Med Wochenschr | Intracellular lipid accumulation and shift during diabetes progression. | 2014 | Details |
| A21784 | 29159094 | J Clin Transl Endocrinol | The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A21785 | 25045618 | Curr Hepatol Rep | Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis. | 2014 | Details |
| A21786 | 25045415 | Oxid Med Cell Longev | Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes. | 2014 | Details |
| A21787 | 25045276 | Clin Exp Gastroenterol | Molecular pathways in non-alcoholic fatty liver disease. | 2014 | Details |
| A21788 | 25045230 | J Korean Med Sci | Clinical significance of non-alcoholic fatty liver disease as a risk factor for prehypertension. | 2014 | Details |
| A21789 | 25044355 | Liver Transpl | Weight gain after orthotopic liver transplantation: is nonalcoholic fatty liver disease cirrhosis a risk factor for greater weight gain? | 2014 | Details |
| A21790 | 25044260 | Microsc Res Tech | Animal models are reliably mimicking human diseases? A morphological study that compares animal with human NAFLD. | 2014 | Details |
| A21791 | 25043514 | Hepatology | Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. | 2014 | Details |
| A21792 | 25043405 | Hepatology | Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibition. | 2014 | Details |
| A21794 | 25040931 | Hepatol Res | Measurement of liver stiffness as a non-invasive method for diagnosis of non-alcoholic fatty liver disease. | 2014 | Details |
| A21795 | 25040896 | J Gastroenterol Hepatol | PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A21796 | 25040043 | Liver Int | microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. | 2014 | Details |
| A21797 | 25039333 | J Gastroenterol Hepatol | Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | 2014 | Details |
| A21798 | 25038727 | Metabolism | Metabolically healthy obesity from childhood to adulthood - Does weight status alone matter? | 2014 | Details |
| A21799 | 25036839 | Biosci Biotechnol Biochem | Attenuation by a Vigna nakashimae extract of nonalcoholic fatty liver disease in high-fat diet-fed mice. | 2014 | Details |
| A21800 | 25035929 | Biochem Biophys Res Commun | PKCδ regulates hepatic triglyceride accumulation and insulin signaling in Lepr(db/db) mice. | 2014 | Details |
| A21801 | 25035342 | Arterioscler Thromb Vasc Biol | Links between ectopic fat and vascular disease in humans. | 2014 | Details |
| A21802 | 25034293 | Dig Dis | Treatment of non-alcoholic fatty liver disease. | 2014 | Details |
| A21803 | 25034292 | Dig Dis | Non-alcoholic fatty liver disease: diagnosis and investigation. | 2014 | Details |
| A21804 | 25034287 | Dig Dis | The pathogenesis of hepatocellular carcinoma. | 2014 | Details |
| A21805 | 25034283 | Dig Dis | The inflammasome in liver injury and non-alcoholic fatty liver disease. | 2014 | Details |
| A21806 | 25034126 | J Virol Methods | Free circulating nucleic acids in plasma and serum as a novel approach to the use of internal controls in real time PCR based detection. | 2014 | Details |
| A21807 | 25032181 | Clin Mol Hepatol | Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study. | 2014 | Details |
| A21809 | 25032097 | World J Transplant | Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21810 | 25030203 | BMC Vet Res | Hepatic inflammation scores correlate with common carotid intima-media thickness in rats with NAFLD induced by a high-fat diet. | 2014 | Details |
| A21811 | 25030027 | BMC Complement Altern Med | Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity. | 2014 | Details |
| A21812 | 25029454 | Curr Opin Cardiol | Should we expand the concept of coronary heart disease equivalents? | 2014 | Details |
| A21813 | 25028495 | Proc Natl Acad Sci U S A | Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease. | 2014 | Details |
| A21814 | 25028077 | Transl Res | Obesity and the liver: nonalcoholic fatty liver disease. | 2014 | Details |
| A21815 | 25026599 | Biochem Pharmacol | Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice. | 2014 | Details |
| A21816 | 25024624 | World J Gastroenterol | Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation. | 2014 | Details |
| A21817 | 25024607 | World J Gastroenterol | High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. | 2014 | Details |
| A21818 | 25024598 | World J Gastroenterol | Nonalcoholic fatty liver disease and cardiovascular disease. | 2014 | Details |
| A21819 | 25024597 | World J Gastroenterol | Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. | 2014 | Details |
| A21820 | 25024596 | World J Gastroenterol | Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment. | 2014 | Details |
| A21821 | 25024595 | World J Gastroenterol | Experimental models of non-alcoholic fatty liver disease in rats. | 2014 | Details |
| A21822 | 25024594 | World J Gastroenterol | Nonalcoholic fatty liver disease and polycystic ovary syndrome. | 2014 | Details |
| A21823 | 25024593 | World J Gastroenterol | Modern approach to the clinical management of non-alcoholic fatty liver disease. | 2014 | Details |
| A21824 | 25024592 | World J Gastroenterol | Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis. | 2014 | Details |
| A21825 | 25023188 | Curr Opin Clin Nutr Metab Care | The Mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease. | 2014 | Details |
| A21826 | 25023045 | Indian J Gastroenterol | Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh. | 2014 | Details |
| A21827 | 25019921 | Dtsch Arztebl Int | Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. | 2014 | Details |
| A21828 | 25019654 | Gen Comp Endocrinol | The effect of recombinant adeno-associated virus-adiponectin (rAAV2/1-Acrp30) on glycolipid dysmetabolism and liver morphology in diabetic rats. | 2014 | Details |
| A21829 | 25019404 | Child Obes | Children's Hospital Association consensus statements for comorbidities of childhood obesity. | 2014 | Details |
| A21830 | 25018867 | Frontline Gastroenterol | Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. | 2013 | Details |
| A21831 | 25018854 | World J Hepatol | Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study. | 2014 | Details |
| A21832 | 25017083 | Clin Liver Dis | Recurrence of nonviral liver diseases after liver transplantation. | 2014 | Details |
| A21833 | 25016220 | J Hepatol | Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity. | 2014 | Details |
| A21834 | 25015398 | Abdom Imaging | Cross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitis. | 2015 | Details |
| A21835 | 25015129 | Arch Pharm Res | Autophagy and microRNA dysregulation in liver diseases. | 2014 | Details |
| A21837 | 25013373 | Int J Med Sci | Alanine aminotransferase-old biomarker and new concept: a review. | 2014 | Details |
| A21838 | 25011936 | Gut | Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |